Clinical Trials in Phoenix

Showing 5681-5700 of 16,646 trials

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

NCT06344052

The goal of this clinical trial is to evaluate the efficacy of using SP-002 in participants with locally advanced Basal cell carcinoma. The main question it aims to answer is what the objective response rate for a basal cell carcinoma tumor is following 1 or 3 cycles of SP-002 treatment given as an add-on to hedgehog pathway inhibitor therapy. Researchers will compare the objective response rate for treated Basal cell carcinoma tumors between 3 treatment Arms. * Arm 1 participants will receive daily hedgehog pathway inhibitor, and 3 cycles of SP-002 treatment. * Arm 2 participants will receive daily hedgehog pathway inhibitor, and 1 cycle of SP-002 treatment. * Arm 3 participants will receive daily hedgehog pathway inhibitor only.

Basal Cell Carcinoma

Stamford Pharmaceuticals, Inc.80 participantsStarted Apr 2024

Phoenix, Arizona, United States • Boca Raton, Florida, United States • Coral Springs, Florida, United States +7 more locations

COMPLETEDPhase 2< 1 mile

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

NCT02177695

The primary focus of this study is to see if looking at tumor biomarkers using a program called coexpression extrapolation or "COXEN" may predict a patient's response to chemotherapy before surgery.

Bladder Cancer

SWOG Cancer Research Network237 participantsStarted Aug 2014

Birmingham, Alabama, United States • Fairbanks, Alaska, United States • Phoenix, Arizona, United States +563 more locations

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Find Trials by Condition in Phoenix

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

Umbilical Cord Milking in Non-Vigorous Infants

Air Optix® Night and Day® Aqua Continuous Wear

Viz HCM (ECG Assist) Utilization Workflow Pilot

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Palbociclib in Real World Practice

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors

Acupuncture for Preterm Infants Requiring Eye-exam